Mucormycosis.

Author: ClarkNina M, FishbeinMichael C, LynchJoseph P, ReidGail

Paper Details 
Original Abstract of the Article :
Mucormycosis is an infection caused by a group of filamentous molds within the order Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores into the nares or lungs, or inoculation into disrupted skin or wounds. In developed countries, mucormycosis occurs primarily...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1055/s-0039-3401992

データ提供:米国国立医学図書館(NLM)

Unveiling the Threat of Mucormycosis: A Desert of Challenges

In this study, published in [Journal Name], we journey into the vast and treacherous desert of mucormycosis, a formidable fungal infection. The authors meticulously detail the complexities of this infection, from its diverse modes of transmission to its devastating impact on health.

The Complexities of Mucormycosis

Mucormycosis, caused by filamentous molds within the order Mucorales, can be a formidable foe. It can manifest in various forms, including rhino-orbital-cerebral mucormycosis, pulmonary, cutaneous, and disseminated infections. This diverse presentation makes diagnosis challenging, akin to navigating a labyrinthine desert landscape.

Strategies for Combating Mucormycosis

The study emphasizes the importance of early diagnosis and intervention. Treatment strategies, such as lipid formulations of amphotericin B (LFAB) and triazoles like posaconazole (POSA) and isavuconazole (ISAV), are described in detail. Early surgical intervention also plays a crucial role in managing this aggressive infection.

Dr. Camel's Conclusion

Mucormycosis is a formidable opponent, but with a comprehensive understanding of its pathogenesis and timely intervention, we can effectively combat this threat. This research serves as a valuable guide for healthcare professionals and researchers, helping to navigate the challenging desert of mucormycosis.

Date :
  1. Date Completed 2020-12-31
  2. Date Revised 2020-12-31
Further Info :

Pubmed ID

32000287

DOI: Digital Object Identifier

10.1055/s-0039-3401992

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.